Pfizer to Acquire Array BioPharma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.33 +0.69 (14.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.64 | 52 Week High | $7.27 | |||
| Open | $5.13 | 52 Week Low | $2.39 | |||
| Day High | $5.96 | P/E | N/A | |||
| Day Low | $5.08 | EPS | $-0.61 | |||
| Volume | 59,375,614 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.79 +0.79 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $37.39 | |||
| Open | $30.75 | 52 Week Low | $28.25 | |||
| Day High | $30.90 | P/E | 18.66 | |||
| Day Low | $30.04 | EPS | $1.65 | |||
| Volume | 50,598,958 | |||||
